#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

ALK gene rearrangement positive

1 clinical trial

Quick filters

Clinical trials for ALK gene rearrangement positive

1 trial across Europe

See all trials →

Quick filters

1 Clinical trial

Non-small cell lung cancer stage IV+2

Not recruiting

Registered drugNo placebo

Study comparing brigatinib alone versus brigatinib with carboplatin and pemetrexed combination as first treatment for patients with advanced ALK-positive lung cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Brigatinib
Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Contact Research Centre

See all trials →

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.